Crescenta Biosciences benefits from key Scientific Advisers and Thought-Leaders in the areas of Medicinal Chemistry, Drug Development, Chemo-Proteomics, Virology, and Metabolic Disease Research.
Current members of the Scientific Advisory Board include:
Patrick Lam, Ph.D.
Former Director of the Discovery Chemistry Department at Bristol-Myers Squibb. Dr. Lam has more than 30 years of experience in the field of medicinal chemistry. He is the co-inventor of a total of eight clinical candidates and the blockbuster anticoagulant drug Eliquis®/Apixaban (PhD in Organic Chemistry, University of Rochester; postdoc, Jung lab, UCLA)
Lynn Enquist, Ph.D.
Henry L. Hillman Professor of Molecular Biology and the Princeton Neuroscience Institute. Dr. Enquist is a world-renowned leader in the area of molecular biology & virology with years of pharma experience in companies such as Du Pont and Du Pont-Merck. He is a Fellow of the American Academy of Microbiology and the American Association for the Advancement of Sciences (AAAS), and the president of the American Society for Microbiology. (PhD in Microbiology, Medical College of Virginia; postdoc, Skalka lab, Roche Institute of Mol. Bio.)